LOW DOSE ORAL FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH UNTREATED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Forconi, F. [1 ]
Fabbri, A. [1 ]
Lenoci, M. [1 ]
Sozzi, E. [1 ]
Bocchia, M. [1 ]
Gozzetti, A. [1 ]
Tassi, M. [1 ]
Raspadori, D. [1 ]
Lauria, F. [1 ]
机构：
[1] Univ Siena, I-53100 Siena, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0093
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Low dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and refractory chronic lymphocytic leukemia
    Forconi, Francesco
    Toraldo, F.
    Sozzi, E.
    Lenoci, M.
    Fabbri, A.
    Gozzetti, A.
    Tassi, M.
    Raspadori, D.
    Lauria, Francesco
    BLOOD, 2007, 110 (11) : 612A - 612A
  • [2] LOW DOSE ORAL FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH UNTREATED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (RETROSPECTIVE STUDY)
    Ionita, H.
    Ionita, I.
    Nicola, D. E.
    Pacurar, R.
    Ionita, C. O.
    Cheveresan, M.
    Borzak, G.
    Ionita, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 523 - 524
  • [3] Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia
    Forconi, Francesco
    Fabbri, Alberto
    Lenoci, Mariapia
    Sozzi, Elisa
    Gozzetti, Alessandro
    Tassi, Maristella
    Raspadori, Donatella
    Lauria, Francesco
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (04) : 247 - 251
  • [4] Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy
    Marotta, G
    Bigazzi, C
    Lenoci, M
    Tozzi, M
    Bocchia, M
    Lauria, F
    HAEMATOLOGICA, 2000, 85 (12) : 1268 - 1270
  • [5] Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia
    Foon, Kenneth A.
    Boyiadzis, Michael
    Land, Stephanie R.
    Marks, Stanley
    Raptis, Anastasios
    Pietragallo, Louis
    Meisner, Dennis
    Laman, Andrew
    Sulecki, Mathew
    Butchko, Allyson
    Schaefer, Patricia
    Lenzer, Diana
    Tarhini, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 498 - 503
  • [6] Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders
    Fabbri, A
    Lenoci, M
    Gozzetti, A
    Marotta, G
    Raspadori, D
    Forconi, F
    Lauria, F
    HEMATOLOGY JOURNAL, 2004, 5 (06) : 472 - 474
  • [7] Oral fludarabine plus cyclophosphamide in elderly patients with relapsed/refractory chronic lymphoproliferative disorders
    Badea, M
    Badea, D
    Genunchhe, A
    ANNALS OF ONCOLOGY, 2005, 16 : 203 - 203
  • [8] Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
    Gritti, Giuseppe
    Reda, Gianluigi
    Maura, Francesco
    Piciocchi, Alfonso
    Baldini, Luca
    Molica, Stefano
    Neri, Antonino
    Cortelezzi, Agostino
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 424 - 429
  • [9] Oral fludarabine and cyclophosphamide plus rituximab in the treatment of the chronic lymphocytic leukemia.
    Casula, P
    Sorano, G
    Pulixi, D
    Culurgioni, F
    Angelucci, E
    BLOOD, 2005, 106 (11) : 341B - 342B
  • [10] Low doses of oral fludarabine in previously untreated elderly patients affected by chronic lymphocytic leukemia: Experience of a single unit
    Quirino, A. A.
    Villa, M. R.
    Improta, S.
    Lucania, A.
    Sagristani, M.
    Correale, F.
    Mastrullo, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 116 - 116
12345